Fuan Pharmaceutical (Group) co.,Ltd.
Summary
Revenue :
000,000 M USD
Finance :
000,000 M USD
Earning Cap :
000,000 M USD
Invest :
000,000 M USD
R & D :
0000 People
Growth :
00% AGR
DIGDAL CAP
Overview
| General Introduction | Fu'an Pharmaceutical (Group) Co., Ltd. was established on February 25, 2004. On March 22, 2011, it became the first pharmaceutical group enterprise in Chongqing Changshou Economic and Technological Development Zone to successfully list on the Shenzhen ChiNext. The group has been recognized as a key high-tech enterprise under the National Torch Program, a national intellectual property advantage enterprise, a high-tech enterprise in Chongqing, an innovative enterprise in Chongqing, a technological innovation demonstration enterprise in Chongqing, an enterprise technology center in Chongqing, an anti-tumor drug engineering technology research center in Chongqing, and a master's student practice base at the School of Pharmacy of Chongqing Medical University. At the same time, the group has also undertaken and participated in multiple national and Chongqing municipal special projects, including the "11th Five Year Plan" and "12th Five Year Plan" major new drug development projects, national innovation fund projects, Chongqing science and technology research projects, Chongqing private economy special fund plan projects, Chongqing science and technology research and development base capacity improvement projects, Chongqing strategic emerging industry development fund projects, major integration demonstration special projects Chongqing Enterprise Independent Innovation Guidance Special Project, Chongqing Key Common Technology R&D and Product Development Theme Special Project, and multiple heavyweight products have won the title of municipal major new product and received national policy support. In 2020, it was rated as one of the top 100 in China's comprehensive drug research and development strength, one of the top 100 in China's chemical drug research and development strength, one of the top 100 in Chongqing's manufacturing industry, the Key Laboratory of Industry and Information Technology of the Chongqing Municipal Commission of Economy and Information Technology, a new type of research and development institution in Chongqing, and a postdoctoral research workstation. Among them, 1/3 had a bachelor's degree or above, and the talent ladder and structure were reasonable. The company always adheres to the business philosophy of "people-oriented, technology first, innovation as the soul, and the pursuit of excellence", actively promotes the optimization of product structure, accelerates the industrialization of product research and research results, and strives to complete the strategic adjustment from the dominant position of antibiotic products to the coordinated development of antibiotics and specialized drugs, laying a solid foundation for the company's future development. |
| Headquarter | Chongqing |
| Establish Date | 2/25/2004 |
| Listed Code | 300194.SZ |
| Listed Date | 3/22/2011 |
| Chairman | Wang Tianxiang. |
| CEO | Wang Tianxiang. |
| Website | www.fapharm.com |
Buy Premium Now
$15/month billed now
View the full stack of insights immediately
Or 7 Days Free Charge for Trial
See feature available in the Trial and Premium
See our Solution and Servicetrial.solutionservice.trial
See our Uniquness and Value deliveringtrial.solutionservice.trial
